Shares of Gilead Sciences, down 23.8% over the past six months, rose on Friday after declaring its drug Remdesivir “the first and only currently approved drug for the treatment of COVID-19 in the United States”. On Thursday, the US Food and Drug Administration (FDA) gave Gilead Sciences approval to sell Remdesivir to medical companies after […]